Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Norwegian Cruise Line Holdings Ltd (NCLH) vs Teladoc Health Inc (TDOC) Price & Performance

Norwegian Cruise Line Holdings LtdTrade
Teladoc Health IncTrade

Price performance (Past 24H)

Key statistics

Norwegian Cruise Line Holdings Ltd vs Teladoc Health Inc — how do they compare? Norwegian Cruise Line Holdings Ltd trades at $18.93 (market cap $8.59B), while Teladoc Health Inc trades at $6.64 (market cap $1.24B). The key difference: Norwegian Cruise Line Holdings Ltd is far larger — about 6.9× Teladoc Health Inc's market cap. Which is the better fit depends on your goals.

NCLHTDOC
Market Cap
$8.59B$1.24B
Sector
Consumer CyclicalHealth
52-Week High
$26.94$9.72
52-Week Low
$14.79$4.47
Enterprise Value
$23.40B$1.50B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Norwegian Cruise Line Holdings Ltd

NCLH trades at $18.93, up 2.05% today, with a bearish technical signal but strong fundamentals including a P/E of 11.33 and net income margin of 7.49%. Recent Q2 2026 earnings beat expectations at $0.48 per share, though revenue growth faces headwinds from high costs. Analyst consensus is a buy with a $20.73 price target, but news highlights concerns over fuel expenses and demand.

The outlook is mixed: valuation metrics suggest upside potential, but risks from macroeconomic pressures and execution challenges persist. Investors may find opportunity if turnaround plans gain traction, yet volatility from operational costs and travel demand fluctuations warrants caution for near-term performance.

Teladoc Health Inc

Teladoc Health (TDOC) trades at $6.62, down 6.5% on the day, reflecting investor concern after a Q2 2026 revenue miss and lowered full-year guidance. The stock is technically bearish with key support at $6, while fundamentals show revenue of $2.53B in 2025 but persistent net losses, with a negative net income margin of -7.13%. Recent news highlights multiple law firm investigations into the company following its guidance cut.

The outlook remains challenging due to weak BetterHelp performance and ongoing losses, though valuation ratios like P/S of 0.49 and EV/EBITDA of 6.96 suggest potential undervaluation. Risks include competitive pressures and legal scrutiny, but analyst consensus price target of $8.88 implies upside if execution improves.

Returns comparison

Trailing returns across standard periods

About Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.

Read more on NCLH

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC